Langerhans cell histiocytosis
Author:
- 1 November 2001
- journal article
- review article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 42 (4) , 237-242
Abstract
SUMMARY: Langerhans cell histiocytosis is a rare condition that can affect any organ of the body. Patients of all ages may present to the dermatologist and it is important to make the diagnosis as quickly as possible, because time from presentation to diagnosis is of prognostic importance in adults with the disease. Langerhans cell histiocytosis is now classified as a class I histiocytosis and research into this disease has been very active over the past 10 years. We now know that the disease represents a clonal expansion of a Langerhans cell, which shows phenotypic evidence of activation. The tissue damage induced by the disease appears to be related to local cytokine release.In single system disease, Langerhans cell histiocytosis is responsive to local therapy but, in resistant single system disease or in multisystem disease, etoposide is the most effective monochemotherapy. Some patients will need maintenance treatment with azathioprine or 6‐mercaptopurine with or without methotrexate. In such cases, physicians who are used to treating chronic and relapsing diseases and who have experience with these drugs, such as dermatologists, are the most appropriate to manage patients with Langerhans cell histiocytosis.Keywords
This publication has 10 references indexed in Scilit:
- Novel Endogenous Type D Retroviral Particles Expressed at High Levels in a SCID Mouse Thymic LymphomaJournal of Virology, 1999
- LANGERHANS CELL HISTIOCYTOSIS OF THE SKINHematology/Oncology Clinics of North America, 1998
- CENTRAL NERVOUS SYSTEM DISEASE IN LANGERHANS CELL HISTIOCYTOSISHematology/Oncology Clinics of North America, 1998
- Langerhans cell histiocytosis-clinicopathological reappraisal and human leucocyte antigen associationBritish Journal of Dermatology, 1996
- Definitive Diagnosis with the Use of Monoclonal Antibody O10 on Routinely Paraffin-embedded SamplesAmerican Journal of Surgical Pathology, 1995
- Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative DiseaseNew England Journal of Medicine, 1994
- Clonal proliferation of Langerhans cells in Langerhans cell histiocytosisThe Lancet, 1994
- Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Report of two cases and literature reviewArchives of Dermatology, 1993
- Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'.Archives of Disease in Childhood, 1992
- U. S. Mortality from Letterer-Siwe Disease, 1960-1964Pediatrics, 1968